返回期刊详情
M
Metabolic Syndrome and Related Disorders
IF1.7
论文数39
被引数2292
期刊论文 39
发表时间
Semaglutide-Induced Weight Loss Is the Main Determinant for the Improvement of Hepatic Biochemistry and Elastographic Repeated Measurements with FibroScan® in Patients with Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Steatotic Liver Disease司美格鲁肽诱导的体重减轻是改善2型糖尿病合并代谢功能障碍相关脂肪性肝病患者的肝生化指标和FibroScan®弹性图重复测量的主要决定因素

